Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting mTOR and NGFR Pathways. Science Essence Journal, [S. l.], v. 42, n. 1, p. 50–70, 2026. DOI: 10.69523/sej.2026.42.17130. Disponível em: https://ejournals.swu.ac.th/sej/article/view/17130. Acesso em: 23 oct. 2026.